Recalls & Warnings July 23, 2016 Seller of GlucoCor Warned for Drug Claims On June 30, 2016, the FDA issued a warning letter to MC-COR, LLC, following a review of the company's website and Facebook page which found statements made about its GlucoCor capsules to be drug claims
P 0.05), demonstrating a clear exacerbation of systemic inflammatory status in male mice
The letters alleged that some of the words used in advertising the products gave rise to an Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers over the Internet. The FDA demanded immediate action, suggesting the online marketers cease and desist from using the language cited in the FDAs warning letter from their online advertising
TB-500 is a synthetic version of a naturally occurring peptide called thymosin beta-4, which is involved in cellular movement and tissue repair throughout the body
This medication improves metabolic function by increasing energy expenditure and reducing insulin resistance
Grx3, Grx4, and Grx5